Menu
Back to User profile » Dr Peng Luo
Papers published by Dr Peng Luo:
Mutations Status of NOTCH Signaling Pathway Predict Prognosis of Immune Checkpoint Inhibitors in Colorectal Cancer
Lin A, Yao J, Cheng Q, Liu Z, Luo P, Zhang J
Journal of Inflammation Research 2023, 16:1693-1709
Published Date: 17 April 2023
B Cell Receptor Signaling Pathway Mutation as Prognosis Predictor of Immune Checkpoint Inhibitors in Lung Adenocarcinoma by Bioinformatic Analysis
Lin A, Fang J, Cheng Q, Liu Z, Luo P, Zhang J
Journal of Inflammation Research 2022, 15:5541-5555
Published Date: 23 September 2022
THSD7B Mutation Induces Platinum Resistance in Small Cell Lung Cancer Patients
Yao Z, Lin A, Yi Y, Shen W, Zhang J, Luo P
Drug Design, Development and Therapy 2022, 16:1679-1695
Published Date: 3 June 2022
Applications of Machine Learning to Predict Cisplatin Resistance in Lung Cancer
Gao Y, Lyu Q, Luo P, Li M, Zhou R, Zhang J, Lyu Q
International Journal of General Medicine 2021, 14:5911-5925
Published Date: 21 September 2021
A novel mutation panel for predicting etoposide resistance in small-cell lung cancer
Qiu Z, Lin A, Li K, Lin W, Wang Q, Wei T, Zhu W, Luo P, Zhang J
Drug Design, Development and Therapy 2019, 13:2021-2041
Published Date: 21 June 2019
Systematic review and meta-analysis of the benefit of celecoxib in treating advanced non-small-cell lung cancer
Yi L, Zhang W, Zhang H, Shen J, Zou J, Luo P, Zhang J
Drug Design, Development and Therapy 2018, 12:2455-2466
Published Date: 7 August 2018
Pharmacological mechanism of roflumilast in the treatment of asthma–COPD overlap
Zhang X, Chen Y, Fan L, Ye J, Fan J, Xu X, You D, Liu S, Chen X, Luo P
Drug Design, Development and Therapy 2018, 12:2371-2379
Published Date: 1 August 2018
The efficacy and safety of alectinib in the treatment of ALK+ NSCLC: a systematic review and meta-analysis
Fan JS, Xia ZF, Zhang XL, Chen YQ, Qian RL, Liu SH, You DM, Zhang J, Luo P
OncoTargets and Therapy 2018, 11:1105-1115
Published Date: 1 March 2018
Glia maturation factor-β: a potential therapeutic target in neurodegeneration and neuroinflammation
Fan J, Fong T, Chen X, Chen C, Luo P, Xie H
Neuropsychiatric Disease and Treatment 2018, 14:495-504
Published Date: 9 February 2018
The applications of liquid biopsy in resistance surveillance of anaplastic lymphoma kinase inhibitor
Chen Y, Guo W, Fan J, Chen Y, Zhang X, Chen X, Luo P
Cancer Management and Research 2017, 9:801-811
Published Date: 7 December 2017
The coexpression of multi-immune inhibitory receptors on T lymphocytes in primary non-small-cell lung cancer
Guo WJ, Liu SH, Zhang XL, Chen YT, Qian RL, Zou ZY, Chen X, Luo P
Drug Design, Development and Therapy 2017, 11:3367-3376
Published Date: 28 November 2017